ライフサイエンスコーパス: pergolide

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 and the putative neuroprotective effects of pergolide.

2 Intracortical pergolide (1 microM, 60 min) was associated with a prolo

3 ptor agonists cabergoline (a D2 agonist) and pergolide (a D1/D2 agonist) administered in separate ses

4 d (a Bruton's tyrosine kinase inhibitor) and pergolide (a dopamine and serotonin receptor agonist) ro

5 Pergolide also caused vasoconstriction in rat pulmonary

6 irole, 7-hydroxy-dipropylamin-otetralin, and pergolide also induced sensitization, whereas the high a

7 e selective for D2-like receptors, with only pergolide and apomorphine potentially interacting with D

8 e and dexfenfluramine, the dopamine agonists pergolide and cabergoline, and more recently, the recrea

9 We also report that pergolide and dihydroergotamine, two drugs recently demo

10 The combination of pergolide and ondansetron normalized not only behavioral

11 Like low dopamine, the D3 receptor agonists pergolide and PD 128907 reduced MSR amplitude in WT but

12 for the WT receptor using bromocriptine- or pergolide- as templates.

13 In this instance both the bromocriptine- and pergolide-based CoMFA models were similar to one another

14 The pergolide-based S193A model was more strikingly differen

15 Pergolide causes Kv channel inhibition and, despite bein

16 o and cabergoline conditions, but not in the pergolide condition.

17 Pergolide directly inhibited heterologously expressed Kv

18 Pergolide enhanced hypoxic pulmonary vasoconstriction in

19 eriments (e.g., during 10 microM dopamine or pergolide in WT), polysynaptic reflexes were facilitated

20 indings suggest that clinical monitoring for pergolide-induced PAH should be considered.

21 Pergolide inhibited PASMC potassium current density, res

22 tive dopamine receptor agonists SKF38393 and pergolide into the medial prefrontal cortex (mPfc) on lo

23 In rats treated with pergolide mesylate (7 days 0.5 mg/kg/day, i.p.), the ave

24 -associated medications (e.g., fenfluramine, pergolide, methysergide, and cabergoline) have revealed

25 ted with pergolide use, we hypothesized that pergolide might have similar effects on hypoxic pulmonar

26 Pergolide produces clinical benefit in Parkinson disease

27 This suggests that pergolide treatment leads to an increased ability of str

28 Although PAH has not been associated with pergolide use, we hypothesized that pergolide might have

29 eart valve disease (CLHVD) has been noted in pergolide users, reminiscent of that induced by certain

30 Pergolide was chosen as an alternate template because it

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。